CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Eagle Pharm - EGRX CFD

-
0%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 -
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024068%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* N/A
开盘价* N/A
1 年变化* N/A
日范围* N/A
52 周范围 23.87-52.22
平均交易量(10 天) 347.18K
平均交易量(3 个月) 3.31M
市值 334.14M
市盈率 9.32
流通股 13.02M
收入 316.61M
EPS 2.76
股息(收益率 %) N/A
贝塔 0.92
下一个财报发布日期 May 8, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low

Eagle Pharm Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018 2017
总收入 171.546 187.802 195.892 213.312 236.707
收入 171.546 187.802 195.892 213.312 236.707
收入成本,共计 42.18 45.465 60.897 61.916 57.186
毛利 129.366 142.337 134.995 151.396 179.521
总营业费用 168.777 154.848 174.077 176.696 162.717
销售/一般/行政费用,总计 75.322 78.598 76.37 60.509 71.416
研究与开发 51.275 30.785 36.81 44.419 32.607
异常费用(收入) 0 0 10.615 8.885
营业收入 2.769 32.954 21.815 36.616 73.99
利息收入(费用),非经营净值 -7.275 -2.015 -0.517 -2.578 -1.045
其他,净值 -0.042 -8.262 0.7
税前净收入 -4.548 22.677 21.998 34.038 72.945
税后净收入 -8.627 11.989 14.313 31.903 55.343
未计算非常项目前的净收益 -8.627 11.989 14.313 31.903 55.343
净收入 -8.627 11.989 14.313 31.903 51.943
Total Adjustments to Net Income
普通股股东可获收益 (不含非经常性项目) -8.627 11.989 14.313 31.903 55.343
普通股股东可获收益 (含非經常性項目) -8.627 11.989 14.313 31.903 51.943
摊薄净收入 -8.627 11.989 14.313 31.903 51.943
摊薄后加权平均股 13.0511 13.7714 14.1387 15.2787 15.9082
扣除特别项目的每股摊薄盈利 -0.66102 0.87057 1.01233 2.08808 3.4789
每股正常摊薄盈利 -0.66102 0.87057 1.01233 2.73926 3.90264
Other Operating Expenses, Total 0 0 -0.763 -7.377
非常规项目总计 -3.4
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 115.874 42.32 39.853 48.124 41.249
收入 115.874 42.32 39.853 48.124 41.249
收入成本,共计 27.755 12.309 8.259 10.757 10.855
毛利 88.119 30.011 31.594 37.367 30.394
总营业费用 56.045 36.421 50.03 37.304 45.022
销售/一般/行政费用,总计 22.182 20.325 18.482 16.636 19.879
研究与开发 6.108 3.787 23.289 9.911 14.288
营业收入 59.829 5.899 -10.177 10.82 -3.773
利息收入(费用),非经营净值 -2.712 -4.53 -2.499 -5.459 5.213
其他,净值 0.543 -0.145 0.016 0.187 -0.1
税前净收入 57.66 1.224 -12.66 5.548 1.34
税后净收入 44.058 -6.196 -5.622 3.612 -0.421
未计算非常项目前的净收益 44.058 -6.196 -5.622 3.612 -0.421
净收入 44.058 -6.196 -5.622 3.612 -0.421
普通股股东可获收益 (不含非经常性项目) 44.058 -6.196 -5.622 3.612 -0.421
普通股股东可获收益 (含非經常性項目) 44.058 -6.196 -5.622 3.612 -0.421
摊薄净收入 44.058 -6.196 -5.622 3.612 -0.421
摊薄后加权平均股 12.9068 12.8948 13.0773 13.2622 13.0694
扣除特别项目的每股摊薄盈利 3.41355 -0.4805 -0.42991 0.27235 -0.03221
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 3.41355 -0.4805 -0.42991 0.27235 -0.03221
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 172.606 166.065 179.449 163.844 188.697
现金和短期投资 97.659 103.155 109.775 78.791 114.657
现金等价物 97.659 103.155 109.775 78.791 114.657
应收账款总额,净额 41.149 51.117 48.004 66.486 53.821
Accounts Receivable - Trade, Net 41.149 51.117 48.004 66.486 53.821
Total Inventory 21.908 8.075 6.566 8.304 5.118
Prepaid Expenses 11.89 3.718 15.104 10.263 15.101
Total Assets 253.732 253.19 254.554 238.603 270.06
Property/Plant/Equipment, Total - Net 1.636 2.077 5.918 2.397 6.82
Property/Plant/Equipment, Total - Gross 7.591 7.268 10.237 5.744 9.258
Accumulated Depreciation, Total -5.955 -5.191 -4.319 -3.347 -2.438
Goodwill, Net 39.743 39.743 39.743 39.743 39.743
Intangibles, Net 10.671 12.917 15.583 18.103 23.322
Other Long Term Assets, Total 29.076 32.388 13.861 14.516 11.478
Total Current Liabilities 74.376 38.085 38.823 39.686 47.302
Accounts Payable 16.431 6.268 5.462 9.917 27.036
Accrued Expenses 32.338 23.817 28.361 23.519 15.391
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total
Total Liabilities 77.279 67.179 75.38 77.841 90.916
Total Long Term Debt 0 25.135 33.557 38.155 42.905
Other Liabilities, Total 2.903 3.959 3 0 0.709
Total Equity 176.453 186.011 179.174 160.762 179.144
Common Stock 0.017 0.017 0.017 0.017 0.016
Additional Paid-In Capital 325.779 305.403 278.518 256.458 233.639
Retained Earnings (Accumulated Deficit) 75.862 84.489 72.5 58.187 26.284
Treasury Stock - Common -225.111 -203.898 -171.861 -153.9 -80.795
Total Liabilities & Shareholders’ Equity 253.732 253.19 254.554 238.603 270.06
Total Common Shares Outstanding 12.7914 13.057 13.6302 13.914 14.8477
Current Port. of LT Debt/Capital Leases 25.607 8 5 6.25 4.875
Long Term Debt 0 25.135 33.557 38.155 42.905
Redeemable Preferred Stock 0 0 0 0
Other Equity, Total -0.094
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 240.166 172.606 171.694 175.504 163.986
现金和短期投资 69.522 97.659 99.741 108.717 105.229
现金等价物 69.522 97.659 99.741 108.717 105.229
应收账款总额,净额 130.858 41.149 47.081 52.659 44.868
Accounts Receivable - Trade, Net 130.858 41.149 45.335 52.659 44.868
Total Inventory 24.818 21.908 9.315 8.294 6.862
Prepaid Expenses 14.968 11.89 15.557 5.834 7.027
Total Assets 320.165 253.732 256.261 264.242 259.968
Property/Plant/Equipment, Total - Net 1.627 1.636 1.775 1.967 2.27
Property/Plant/Equipment, Total - Gross 7.759 7.591 7.542 7.537 7.652
Accumulated Depreciation, Total -6.132 -5.955 -5.767 -5.57 -5.382
Goodwill, Net 39.743 39.743 39.743 39.743 39.743
Intangibles, Net 9.94 10.671 10.799 11.505 12.211
Other Long Term Assets, Total 28.689 29.076 32.25 35.523 41.758
Total Current Liabilities 101.642 74.376 48.431 44.664 41.973
Accounts Payable 14.509 16.431 12.717 11.136 12.559
Accrued Expenses 63.408 32.338 27.714 25.528 21.414
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 23.725 25.607 8 8 8
Total Liabilities 104.205 77.279 70.968 69.395 68.89
Total Long Term Debt 0 0 19.489 21.371 23.253
Long Term Debt 0 19.489 21.371 23.253
Other Liabilities, Total 2.563 2.903 3.048 3.36 3.664
Total Equity 215.96 176.453 185.293 194.847 191.078
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.017 0.017 0.017 0.017 0.017
Additional Paid-In Capital 328.769 325.779 320.566 316.249 312.323
Retained Earnings (Accumulated Deficit) 119.92 75.862 82.058 87.68 84.068
Treasury Stock - Common -233.164 -225.111 -216.466 -208.195 -205.33
Total Liabilities & Shareholders’ Equity 320.165 253.732 256.261 264.242 259.968
Total Common Shares Outstanding 12.6971 12.7914 12.9446 13.0971 13.1455
Other Equity, Total 0.418 -0.094 -0.882 -0.904
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 -8.627 11.989 14.313 31.903 51.943
经营活动产生的现金 28.219 49.497 55.986 52.384 58.919
经营活动产生的现金 0.764 0.872 2.131 1.155 0.932
Amortization 2.996 2.666 2.52 2.515 2.815
Deferred Taxes -3.618 -1.511 0.152 -2.468 17.289
非现金物品 27.167 34.665 22.478 27.168 15.509
Cash Taxes Paid 10.005 6.428 6.673 2.281 10.542
已付现金利息 1.197 2.224 2.478 2.084 0.651
营运资金的变化 9.537 0.816 14.392 -7.889 -29.569
投资活动产生的现金 -5.323 -18.247 -0.777 -0.133 -5.186
资本支出 -0.323 -0.747 -0.777 -0.133 -5.186
其他投资现金流量项目,总计 -5 -17.5 0 0
融资活动产生的现金 -28.392 -37.87 -24.225 -88.117 8.104
融资现金流项目 -1.577 -1.525 -0.524 -19.877 -1.192
股票的发行(报废),净额 -18.815 -31.345 -17.701 -64.49 -39.454
现金净变化 -5.496 -6.62 30.984 -35.866 61.837
债务的发行(退还),净额 -8 -5 -6 -3.75 48.75
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line 44.058 -8.627 -2.431 3.191 -0.421
Cash From Operating Activities -16.611 28.219 20.138 19.071 10.478
Cash From Operating Activities 0.177 0.764 0.575 0.378 0.19
Amortization 0.731 2.996 2.118 1.412 0.706
Deferred Taxes -2.432 -3.618 -2.533 1.119 0.902
Non-Cash Items 6.616 27.167 17.689 10.989 1.378
Cash Taxes Paid 0.041 10.005 6.303 4.3 0.267
Cash Interest Paid 0.265 1.197 0.917 0.625 0.321
Changes in Working Capital -65.761 9.537 4.72 1.982 7.723
Cash From Investing Activities -0.168 -5.323 -5.274 -5.269 -5.384
Capital Expenditures -0.168 -0.323 -0.274 -0.269 -0.384
Other Investing Cash Flow Items, Total 0 -5 -5 -5 -5
Cash From Financing Activities -11.358 -28.392 -18.278 -8.24 -3.02
Financing Cash Flow Items -1.305 -1.577 -1.551 -1.551 -1.551
Issuance (Retirement) of Stock, Net -8.053 -18.815 -10.727 -2.689 0.531
Issuance (Retirement) of Debt, Net -2 -8 -6 -4 -2
Net Change in Cash -28.137 -5.496 -3.414 5.562 2.074
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
BlackRock Institutional Trust Company, N.A. Investment Advisor 12.5669 1635783 7863 2022-12-31 LOW
Tarriff (Scott L) Individual Investor 12.3402 1606275 70900 2023-03-01 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 9.4485 1229872 -9907 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 7.3139 952026 -59721 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 5.8538 761974 -11708 2022-12-31 LOW
Brandes Investment Partners, L.P. Investment Advisor 3.1973 416177 -51680 2022-12-31 LOW
Adage Capital Management, L.P. Hedge Fund 3.073 400000 150000 2022-12-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 2.6858 349606 -6153 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 2.0485 266650 -7629 2022-12-31 HIGH
Acadian Asset Management LLC Investment Advisor/Hedge Fund 1.7792 231587 -79633 2022-12-31 MED
Smith, Graham & Co. Investment Advisors, L.P. Investment Advisor 1.7764 231222 -799 2022-12-31 LOW
Quoniam Asset Management GmbH Investment Advisor/Hedge Fund 1.766 229871 -55740 2022-12-31 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.5388 200305 3708 2022-12-31 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 1.2517 162931 19807 2022-12-31 LOW
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 1.231 160236 -2596 2022-12-31 LOW
LSV Asset Management Investment Advisor 1.1633 151418 126068 2022-12-31 LOW
Allspring Global Investments, LLC Investment Advisor/Hedge Fund 1.1572 150628 62456 2022-12-31 LOW
Scout Investments, Inc. Investment Advisor 1.0805 140642 -2342 2022-12-31 MED
AQR Capital Management, LLC Investment Advisor/Hedge Fund 1.0396 135315 39400 2022-12-31 LOW
Morgan Stanley & Co. LLC Research Firm 1.0331 134477 -15478 2022-12-31 MED

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Eagle Pharm Company profile

关于 Eagle Pharm

鹰牌制药公司是一家综合性制药公司。 公司将一个分子从临床前研究到监管部门批准并进入市场,包括开发、制造和商业化。 公司确定了具有挑战性的中枢神经系统疾病或代谢性危重病治疗领域以及肿瘤学领域。 该公司提供三种产品。 Ryanodex,丹曲林钠)(Ryanodex),苯达莫司汀即溶(RTD)500毫升溶液(Belrapzo),以及快速输注苯达莫司汀RTD(Bendeka)。 公司销售Ryanodex和Belrapzo,而梯瓦制药工业有限公司(Teva)销售Bendeka。 (Teva)在日本销售盐酸苯达莫司汀的冻干粉制剂Bendeka。

Industry: Proprietary & Advanced Pharmaceuticals

50 Tice Boulevard, Suite 315
WOODCLIFF LAKE
NEW JERSEY 07677
US

收入报表

  • Annual
  • Quarterly

人们也观看

Gold

1,978.85 Price
-0.760% 1D Chg, %
多头隔夜费 -0.0179%
空头隔夜费 0.0097%
隔夜费时间 21:00 (UTC)
价差 0.30

BTC/USD

27,805.00 Price
+0.030% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 66.00

XRP/USD

0.46 Price
+8.320% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00356

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
多头隔夜费 -0.0194%
空头隔夜费 -0.0025%
隔夜费时间 21:00 (UTC)
价差 0.03

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易